MANA neonatologists are available 24 hours a day to provide advanced neonatal care to our patients and support to their families. The infants in our NICUs have access to sophisticated technology and cutting edge therapies in supportive, family-oriented care settings conducive to healing. Our staff employs the most advanced therapies for critically ill infants e.g. high-frequency oscillator and jet ventilation, inhaled nitric oxide, and therapeutic hypothermia. At the same time we actively promote Family-Centered Care, breast-feeding, and Kangaroo Care.
The neonatal staff at MANA participate in the Atlantic Fetal Diagnostic & Treatment Center (AFDTC), a multidisciplinary clinical program focused on providing comprehensive, coordinated care throughout the prenatal and postnatal period for families whose pregnancies are complicated by congenital anomalies in the fetus. AFDTC faculty includes maternal-fetal medicine (MFM) specialists, neonatologists, a medical geneticist, genetic counselors, obstetricians, and an assortment of pediatric medical and surgical sub-specialists. We coordinate care with obstetricians in the community to ensure successful deliveries, and network with all the sub-specialists needed to handle complex postnatal complications.
MANA recognizes that newborns are uniquely fragile patients who face medical challenges which require extraordinary attention. The art and science of neonatal intensive care is evolving rapidly.
Members of MANA conduct research focused on the medical complications of infants in the NICU. We are dedicated to identifying strategies for treating the high-risk infant population, to preventing adverse outcomes for preterm newborns, and to optimizing clinical care. Our team of physicians & scientists participate in investigator-initiated pre-clinical, translational and clinical studies; industry-sponsored research trials, quality improvement initiatives, and a follow-up research clinic.